首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   337篇
  免费   19篇
  国内免费   66篇
耳鼻咽喉   2篇
儿科学   41篇
妇产科学   1篇
基础医学   31篇
口腔科学   25篇
临床医学   59篇
内科学   77篇
皮肤病学   1篇
神经病学   8篇
特种医学   96篇
外科学   12篇
综合类   17篇
预防医学   5篇
药学   35篇
中国医学   2篇
肿瘤学   10篇
  2022年   1篇
  2019年   2篇
  2018年   2篇
  2017年   4篇
  2016年   4篇
  2015年   2篇
  2014年   3篇
  2013年   5篇
  2012年   5篇
  2011年   4篇
  2010年   6篇
  2009年   10篇
  2008年   6篇
  2007年   35篇
  2006年   8篇
  2005年   6篇
  2004年   2篇
  2003年   6篇
  2002年   13篇
  2001年   15篇
  2000年   11篇
  1999年   9篇
  1998年   26篇
  1997年   26篇
  1996年   25篇
  1995年   18篇
  1994年   18篇
  1993年   10篇
  1992年   1篇
  1991年   3篇
  1990年   11篇
  1989年   15篇
  1988年   16篇
  1987年   12篇
  1986年   11篇
  1985年   16篇
  1984年   4篇
  1983年   7篇
  1982年   8篇
  1981年   8篇
  1980年   5篇
  1978年   7篇
  1977年   4篇
  1976年   5篇
  1975年   7篇
排序方式: 共有422条查询结果,搜索用时 15 毫秒
21.
22.
Respiratory function studies were carried out in 22 infants who had successful repair of diaphragmatic herniae of the Bochdalek type. Thoracic gas volume was initially reduced in only 3 of these, but subsequent studies showed that improvement occurred. There were no consistent abnormalities in either dynamic compliance or mean pulmonary conductance. This is evidence that there is rapid adaptation which compensates for any alteration in the parenchymatous tissue in the lungs or abnormalities in the bronchial tree in infants soon after the repair of congenital diaphragmetic herniae. Further studies are necessary to determine the changes in these lungs with growth.  相似文献   
23.
用Harris冠脉结扎法诱发的心律失常狗研究常咯啉药代动力学-药效动力学。7只狗按83.33μg·kg-1·min-1静脉滴注60min,在给药期间和停药后不同时间记录ECG及测定血药浓度。C-T数据用药代程序计算药代参数;药效数据用药代-药效同步分析模型计算药效动力学参数,K10, T1/2,Vd,Cl分别为0.0087min-1,78.03min,40.55ml·kg-1和0.421ml·kg-1·min-1;KeOCe(50)分别为0.0048min-1和2.01μg·ml-1.  相似文献   
24.
  • 1 Autoradiographic binding studies have shown that the AT1 receptor is the predominant angiotensin II (AngII) receptor subtype in the central nervous system (CNS). Major sites of AT1 receptors are the lamina terminalis, hypothalamic paraventricular nucleus, the lateral parabrachial nucleus, rostral and caudal ventrolateral medulla, nucleus of the solitary tract and the intermediolateral cell column of the thoraco-lumbar spinal cord.
  • 2 While there are differences between species, AT2 receptors are found mainly in the cerebellum, inferior olive and locus coeruleus of the rat.
  • 3 Circulating AngII acts on AT1 receptors in the subfornical organ and organum vasculosum of the lamina terminalis (OVLT) to stimulate neurons that may have a role in initiating water drinking.
  • 4 Centrally administered AngII may act on AT1 receptors in the median preoptic nucleus and elsewhere to induce drinking, sodium appetite, a sympathetic vasoconstrictor response and vasopressin secretion.
  • 5 Recent evidence shows that centrally administered AT1 antagonists inhibit dipsogenic, natriuretic, pressor and vasopressin secretory responses to intracerebroventricular infusion of hypertonic saline. This suggests that an angiotensinergic neural pathway has a role in osmoregulatory responses.
  • 6 Central angiotensinergic pathways which include neural inputs to the rostral ventrolateral medulla may use AT1 receptors and play a role in the function of sympathetic pathways maintaining arterial pressure.
  相似文献   
25.
高建华  文广伶  张其楷 《药学学报》1990,25(12):891-897
研究了强效抗胆碱药dl-3-(2-苯基-2-环戊基-2-羟基-乙氧基)-奎宁环烷的四个光学异构体的两种不对称合成方法,用HPLC检测了异构体含量,讨论了构效关系。  相似文献   
26.
香菇多糖的免疫调节作用   总被引:26,自引:0,他引:26  
研究香菇多糖(LTN)的免疫调节作用。结果表明,LTN1及5mg·kg-1·d-1×6,ip可促进正常小鼠由ConA(2.5mg·kg-1)刺激的脾脏T淋巴细胞增殖反应。1,5及10mg·kg-1·d-1×8或5,ip能分别纠正由环磷酰胺(Cy,200mg·kg-1和80mg·kg-1,ip)诱导的免疫亢进或低下状态。此外,LTN(1,5和10mg·kg-1·d-1×6,ip),促使小鼠胸腺L3T4+(Th)和Lyt2+(Ts)细胞数减少,外周脾脏L3T4+和Lyt2+细胞数增加,腹腔巨噬细胞释出肿瘤坏死因子(TNF)也明显增加。这些作用均以LTN5mg·kg-1·d-1作用最佳。提示LTN可能通过影响T细胞及其亚型,促进TNF活性调节机体的免疫功能。  相似文献   
27.
28.
AIMS: Long acting subcutaneous testosterone pellets are of proved efficacy for the treatment of hypogonadal men, but have not been reported as a treatment modality in adolescent boys. Pharmacodynamic studies of subcutaneous testosterone release have shown prolonged normalisation of testosterone levels for at least four months. Administration of a long acting, safe, effective, and convenient form of treatment is desirable when life-long treatment is indicated. PATIENTS AND METHODS: Eighteen boys (aged 13.9-17.5 years at the start of treatment)-seven with primary hypogonadism, nine with secondary hypogonadism, and two boys being treated with testosterone for tall stature--were given testosterone pellets (8-10 mg/kg) every six months for 18 months. Height, weight, pubertal status, and psychosocial parameters were assessed and follicle stimulating hormone, luteinising hormone, testosterone, prolactin, and lipids were measured at 0, 1, 3, 6, 12, and 18 months. Bone age was measured at 0 and 12 months. RESULTS: In all boys growth velocity continued appropriately for bone age. Puberty continued to progress in all boys and in two boys the amount of virilisation exceeded that seen with previous treatment with intramuscular testosterone. After testosterone administration, follicle stimulating hormone and luteinising hormone suppressed incompletely in the boys with primary hypogonadism. Serum testosterone ranged from 4.3 to 26.7 nmol/l at three months to less than 10 nmol/l at six months after implantation. Prolactin and lipid levels were normal throughout the study. By report, there was an improvement in mood and emotional wellbeing. No pellet extrusions occurred in a total of 156 pellet insertions. CONCLUSIONS: All boys preferred this mode of testosterone administration to intramuscular injections. Long acting subcutaneous testosterone pellets are safe, efficacious, well tolerated, and convenient, and result in normal physical growth and improved psychological outlook in adolescent hypogonadal boys.  相似文献   
29.
30.
王玉  陈国良  吴耀民 《医学争鸣》2005,26(10):960-960
在大规模登陆作战中需要大量的卫生船舶实施各种保障,因此必须对卫生船舶进行合理的配置,保证其既能有效地完成保障任务,又能避免重叠配置造成浪费.卫生船舶的配置应与指挥关系、保障任务战时分类相适应,具体配置时按医院船、卫生运输船、卫生救护艇的保障要求配置,并可根据保障任务的变化进行相应的调整.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号